Emmune, Inc. is a start-up biotechnology company that has a novel approach for treating and preventing HIV infection. We engineered a synthetic antibody from the receptors that HIV uses to infect T cells, CD4 and CCR5. Because this synthetic antibody, known as “eCD4-Ig,” is built from the viral receptor and co-receptor, it recognizes 100% of HIV-1 isolates. A single intramuscular inoculation with an AAV vector expressing eCD4-Ig protected monkeys from multiple intravenous challenges with live virus.
View Top Employees from Emmune, Inc.| Website | http://emmune.bio |
| Employees | 6 (6 on RocketReach) |
| Address | 620 Memorial Drive, Cambridge, Massachusetts 02139, US |
| Technologies |
JavaScript,
HTML,
PHP
+10 more
(view full list)
|
| Industry | Biotechnology Research |
Looking for a particular Emmune, Inc. employee's phone or email?
Emmune, Inc. Questions
Kimberly Kelly is the Director of In Vivo Pharmacology of Emmune, Inc..
6 people are employed at Emmune, Inc..
Emmune, Inc. is based in Cambridge, Massachusetts.
Top Emmune, Inc. Employees
-
25+
-
View
Kimberly Kelly
Director of In Vivo Pharmacology at Emmune, Inc.
Jupiter, Florida, United States34 -
2
-
23
-
21
-
ViewKimberly Conkright
Director of in Vivo Pharmacology at Emmune, Inc.
Jupiter, Florida, United States1
Related Companies
